<DOC>
	<DOCNO>NCT00996372</DOCNO>
	<brief_summary>The objective trial ass safety efficacy 24-week course flibanserin treatment Hypoactive Sexual Desire Disorder ( HSDD ) naturally postmenopausal woman .</brief_summary>
	<brief_title>Flibanserin Treatment Hypoactive Sexual Desire Disorder Postmenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Sexual Dysfunctions , Psychological</mesh_term>
	<criteria>Inclusion criterion : Naturally postmenopausal woman age least one ovary Diagnosis Hypoactive Sexual Desire Disorder , generalize acquire type , least six month duration Stable , monogamous heterosexual relationship least one year Willing discus sexual issue Willing engage sexual activity least month Normal Pap smear Normal mammogram Normal uterine lining Able comply daily use handheld data entry device Exclusion criterion : Sexual dysfunction HSDD , Sexual Aversion Disorder , Substanceinduced Sexual Dysfunction , Dyspareunia , Vaginismus , Gender Identity Disorder , Paraphilia Sexual Dysfunction due General Medical Condition Partner inadequately treat organic psychosexual dysfunction Sexual function impair psychiatric disorder Sexual function impair gynecological disorder Major Depression Suicidal behavior ideation Major life stress could impair sexual function Substance abuse</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>